Table 5. Data of oxygen saturation, neuromuscular strength and range of motion in baseline, pretreatment and posttreatment moments.
|
Pretreatment post-treatment intragroup comparison |
|
ES standardized (90% CL) intragroups |
Chances |
QA |
ES standardized (90% CL) between groups |
Chances |
QA |
SmO2 |
Rest |
NVFR |
0.28 (-0.09;0.65) |
64/43/2 |
Possibly |
-0.10 (0.49;-0.70) |
20/41/39 |
Unclear |
VFR |
0.41 (-0.08;0.91) |
77/21/2 |
Likely |
After ten squats |
NVFR |
1.23 (0.44;2.01) |
98/1/0 |
Very likely |
0.21 (0.74;-0.33) |
10/39/51 |
Unclear |
VFR |
0.96 (0.36;1.55) |
98/2/0 |
Very likely |
CMJ |
|
NVFR |
0.42 (0.3;0.54) |
100/0/0 |
Very likely |
-0.09 (-0.24;0.05) |
0/89/11 |
Unclear |
VFR |
0.29 (0.2;0.38) |
95/5/0 |
Very likely |
Hip joint ROM |
Active |
NVFR |
0.53 (0.32;0.73) |
99/1/0 |
Very likely |
0.31 (-0.02;0.64) |
71/28/1 |
Unclear |
VFR |
0.91 (0.63;1.19) |
100/0/0 |
Very likely |
Passive |
NVFR |
0.34 (0.14;0.53) |
88/12/0 |
Likely |
0.36 (0.01;0.72) |
78/22/1 |
Likely |
VFR |
0.71 (0.45;0.97) |
100/0/0 |
Very likely |
Knee joint ROM |
Active |
NVFR |
0.62 (0.48;0.76) |
100/0/0 |
Very likely |
0.19 (-0.01;0.39) |
47/52/0 |
Unclear |
VFR |
0.48 (0.33;0.62) |
100/0/0 |
Very likely |
Passive |
NVFR |
0.43 (0.23;0.63) |
97/3/0 |
Very likely |
0.05 (-0.18;0.28) |
14/82/4 |
Unlikely |
VFR |
0.26 (0.1;0.42) |
74/26/0 |
Possibly |
ES, effect size; CL, confidence limits; QA, qualitative assessment; CMJ, countermovement jump; SmO
2, muscle oxygen saturation; ROM, range of motion.